EYPTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31

EyePoint, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026

$0.44−2.55 (-85.28%)

Close on Oct 19, 2026

Market cap: $38.08K
P/E (TTM): –
Dividend yield: –

EyePoint, Inc. income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2018 2018-06-30	FY 2017 2017-06-30	FY 2016 2016-06-30	FY 2015 2015-06-30	FY 2014 2014-06-30	FY 2013 2013-06-30	FY 2012 2012-06-30	FY 2011 2011-06-30	FY 2010 2010-06-30
Revenue	31	43	46	41	37	34	2.96	7.54	1.62	27	3.47	2.14	3.53	4.97	23
Research & Development	221	133	65	50	29	17	16	15	14	12	9.57	7.01	7.04	6.86	6.99
Selling, General & Admin	52	52	52	60	53	46	13	11	9.01	–	–	–	–	–	–
Selling & Marketing	0.09	0.13	12	26	28	25	1.51	0	0	–	–	–	–	–	–
General & Administrative	52	52	40	35	26	21	12	11	9.01	8.06	7.47	7.17	6.87	8.10	6.97
Operating Expenses	275	189	121	141	92	72	29	26	23	20	17	14	29	15	14
Operating Income	-243	-146	-75	-100	-55	-37	-26	-19	-22	6.42	-13	-12	-25	-10	9.09
Interest Expense	0.03	0.01	1.25	3.19	5.50	7.26	0.72	0	0	–	–	–	–	–	–
Interest & Investment Income	–	–	–	–	–	–	–	–	–	0.02	0.01	0.02	0.04	0.03	0.03
Other Non-Operating Income	12	15	4.36	-2.62	-3.14	-8.10	-27	0.09	0.07	0.02	0.01	0.01	0.21	1.16	-0.32
Merger & Restructuring Charges	–	–	–	–	–	0.59	–	0.47	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	–	–	–	–	–	–	–	–	0	0	0.08	0	–	–	–
Pretax Income	-232	-131	-71	-102	-58	-45	-53	-18	-22	6.44	-13	-12	-25	-8.85	8.78
Income Tax Expense	0.28	0.09	0.08	0	0	0	0	0	-0.16	0.10	-0.13	-0.12	-0.17	-0.22	0.02
Net Income incl. Noncontrolling Interests	-232	-131	-71	-102	-58	-45	-53	-18	-22	–	–	–	–	–	–
Net Income	-232	-131	-71	-102	-58	-45	-53	-18	-22	6.35	-13	-12	-25	-8.63	8.75
EPS (Basic)(per share)	-3.17	-2.32	-1.82	-2.74	-2.03	-3.54	-11.50	-5.20	-6.80	2.20	-4.90	-5.20	-11.90	-4.40	4.80
EPS (Diluted)(per share)	-3.17	-2.32	-1.82	-2.74	-2.03	-3.54	-11.50	-5.20	-6.80	2.10	-4.90	-5.20	-11.90	-4.40	4.60
Shares Outstanding (Basic, Weighted)(shares)	0.07	0.06	0.04	37	29	13	4.62	3.53	3.16	2.94	2.74	2.30	2.08	1.95	1.84
Shares Outstanding (Diluted, Weighted)(shares)	0.07	0.06	0.04	37	29	13	4.62	3.53	3.16	3.06	2.74	2.30	2.08	1.95	1.89
EBITDA	-241	-144	-75	–	–	–	–	–	–	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: -11365.2%
Net margin: -10994.7%
Return on equity, FY2025: -72.2%

Financial strength

Current ratio: 4.50
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 263.4%

Valuation

P/E ratio: –
Price to sales: 0.01
Price to book: 0.00
Dividend yield: –